Spermatogenesis Associated 9 (SPATA9) (N-Term) Peptide
SPATA9
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all SPATA9 products
- SPATA9 (Spermatogenesis Associated 9 (SPATA9))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- FKDEFPTILR LSQSNQKREP AQKTSKIRMA IALAKINRAT LIRGLNSISR
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SPATA9 Antibody(ARP50025_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SPATA9 (Spermatogenesis Associated 9 (SPATA9))
- Background
-
SPATA9 may play a role in testicular development/spermatogenesis and may be an important factor in male infertility. Defects in expression of SPATA9 lead to Sertoli-cell-only syndrome.
Alias Symbols: FLJ35906, NYD-SP16
Protein Size: 254 - Molecular Weight
- 29 kDa
- Gene ID
- 83890
- NCBI Accession
- NM_031952, NP_114158
- UniProt
- Q9BWV2
-
You are here:
